Hankyel Park

Array ( [id] => 6668914 [patent_doc_number] => 20030113898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Methods for producing high titre vectors and compositions used in such methods' [patent_app_type] => new [patent_app_number] => 10/134643 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 37033 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113898.pdf [firstpage_image] =>[orig_patent_app_number] => 10134643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525665 [patent_doc_number] => 20020192641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Measuring viral reverse transcriptase activity' [patent_app_type] => new [patent_app_number] => 10/048936 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3676 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192641.pdf [firstpage_image] =>[orig_patent_app_number] => 10048936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518899 [patent_doc_number] => 20020192196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method and composition for skin grafts' [patent_app_type] => new [patent_app_number] => 10/131977 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9099 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192196.pdf [firstpage_image] =>[orig_patent_app_number] => 10131977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529376 [patent_doc_number] => 20020136690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Detection and treatment of infections with immunoconjugates' [patent_app_type] => new [patent_app_number] => 10/125342 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12442 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136690.pdf [firstpage_image] =>[orig_patent_app_number] => 10125342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860582 [patent_doc_number] => 20030091590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Recombinant rhabdoviruses as live-viral vaccines' [patent_app_type] => new [patent_app_number] => 10/127746 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22038 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091590.pdf [firstpage_image] =>[orig_patent_app_number] => 10127746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175632 [patent_doc_number] => 20020155436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae' [patent_app_type] => new [patent_app_number] => 10/124363 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28031 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155436.pdf [firstpage_image] =>[orig_patent_app_number] => 10124363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625610 [patent_doc_number] => 06723559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'RECOMBINANT SEGMENTED NEGATIVE STRAND VIRUS CONTAINING BICISTRONIC VRNA SEGMENT WITH A DUPLICATION OF ITS 3 NONCODING FLANKING SEQUENCE, AND VACCINES AND THERAPEUTIC COMPOSITIONS CONTAINING THE SAME' [patent_app_type] => B2 [patent_app_number] => 10/123170 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 10639 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723559.pdf [firstpage_image] =>[orig_patent_app_number] => 10123170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982187 [patent_doc_number] => 06927031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Methods for identifying polypeptide factors interacting with RNA' [patent_app_type] => utility [patent_app_number] => 10/122675 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11013 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927031.pdf [firstpage_image] =>[orig_patent_app_number] => 10122675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1269718 [patent_doc_number] => 06653103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => 'Inhibition of nucleocytoplasmic transport by vesicular stomatitis virus M protein-like polypeptides' [patent_app_type] => B2 [patent_app_number] => 10/112802 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 13282 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653103.pdf [firstpage_image] =>[orig_patent_app_number] => 10112802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286912 [patent_doc_number] => 06635449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-21 [patent_title] => 'Exonuclease-mediated nucleic acid reassembly in directed evolution' [patent_app_type] => B2 [patent_app_number] => 10/108077 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 68584 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635449.pdf [firstpage_image] =>[orig_patent_app_number] => 10108077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417314 [patent_doc_number] => 06514758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy' [patent_app_type] => B2 [patent_app_number] => 10/100432 [patent_app_country] => US [patent_app_date] => 2002-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6475 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514758.pdf [firstpage_image] =>[orig_patent_app_number] => 10100432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209057 [patent_doc_number] => 06713282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'End selection in directed evolution' [patent_app_type] => B2 [patent_app_number] => 10/099816 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 65241 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713282.pdf [firstpage_image] =>[orig_patent_app_number] => 10099816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765660 [patent_doc_number] => 20030100060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)' [patent_app_type] => new [patent_app_number] => 10/096246 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12092 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100060.pdf [firstpage_image] =>[orig_patent_app_number] => 10096246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1098288 [patent_doc_number] => 06818199 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Media and methods for enhanced medical imaging' [patent_app_type] => B1 [patent_app_number] => 10/093770 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 11791 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818199.pdf [firstpage_image] =>[orig_patent_app_number] => 10093770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401240 [patent_doc_number] => 06531588 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Methods for HIV sequencing and genotyping' [patent_app_type] => B1 [patent_app_number] => 10/092022 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6028 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531588.pdf [firstpage_image] =>[orig_patent_app_number] => 10092022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5906043 [patent_doc_number] => 20020142394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Exonuclease-mediated gene assembly in directed evolution' [patent_app_type] => new [patent_app_number] => 10/087426 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 42854 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142394.pdf [firstpage_image] =>[orig_patent_app_number] => 10087426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082785 [patent_doc_number] => 06833254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-21 [patent_title] => 'Method to identify IRES elements' [patent_app_type] => B2 [patent_app_number] => 10/087171 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 28 [patent_no_of_words] => 7924 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833254.pdf [firstpage_image] =>[orig_patent_app_number] => 10087171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446667 [patent_doc_number] => 20020177226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants' [patent_app_type] => new [patent_app_number] => 10/076707 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 74399 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177226.pdf [firstpage_image] =>[orig_patent_app_number] => 10076707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247978 [patent_doc_number] => 06673557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Methods of treatment of eye trauma and disorders' [patent_app_type] => B2 [patent_app_number] => 10/060101 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22795 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 266 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673557.pdf [firstpage_image] =>[orig_patent_app_number] => 10060101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196271 [patent_doc_number] => 06727059 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'METHOD FOR CONTROLLING THE FIDELITY AND PROCESSIVITY OF REVERSE TRANSCRIPTASE BY INCORPORATION AND POLYMERIZATION OF NUCLEOTIDE ANALOGS ACCEPTED AS SUBSTRATES FOR THE REVERSE TRANSCRIPTION REACTION WITHOUT BLOCKING ITS ELONGATION' [patent_app_type] => B1 [patent_app_number] => 09/926492 [patent_app_country] => US [patent_app_date] => 2002-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 19256 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727059.pdf [firstpage_image] =>[orig_patent_app_number] => 09926492 [rel_patent_id] =>[rel_patent_doc_number] =>)